last feature in this series.Among them is the finding that a rheumatoid arthritis drug called tocilizumab almost halved COVID-19 mortality.
This drug calms the so-called cytokine storm, which refers to a potentially fatal overreaction of the immune system. However, this drug may also increase the risk of secondary infections.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.In another interesting development, scientists used cutting-edge technology to create air filters that can kill SARS-CoV-2.
The innovation could help stop the new virus from spreading indoors.However, the most promising outcomes are from the field of vaccine testing: Two new vaccines.